Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Lam · SciRah

Researcher profile · Semantic Scholar

B. Lam

Share profile

B. Lam — researcher profile on SciRah

h-index: 24
Works: 120
Citations: 2,376

Most-cited papers

Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof of Concept Phase 2a Cohort Study
A. Kohli, R. Kapoor, Zayani Sims, Amy K. Nelson +13 more
2015Lancet. Infectious Diseases (Print)185 citations Open access
Semantic Scholar
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
Z. Younossi, S. Zelber-Sagi, Jeffrey V. Lazarus, Vincent Wai-Sun Wong +39 more
2025Gastroenterology184 citations Open access
Semantic Scholar
A disease‐specific quality of life instrument for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: CLDQ‐NAFLD
Z. Younossi, M. Stepanova, L. Henry, A. Racila +3 more
2017Liver international (Print)107 citations
Semantic Scholar
The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment
B. Lam, T. Jeffers, Z. Younoszai, Yousef Fazel +1 more
2015Therapeutic Advances in Gastroenterology103 citations Open access
Semantic Scholar
A Global Survey of Physicians Knowledge About Non-alcoholic Fatty Liver Disease.
Z. Younossi, J. Ong, Hirokazu Takahashi, Y. Yılmaz +28 more
2021Clinical Gastroenterology and Hepatology102 citations Open access
Semantic Scholar
The patient's journey with chronic hepatitis C from interferon plus ribavirin to interferon‐ and ribavirin‐free regimens: a study of health‐related quality of life
Z. Younossi, M. Stepanova, F. Nader, B. Lam +1 more
2015Alimentary Pharmacology and Therapeutics99 citations
Semantic Scholar
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
Z. Younossi, Saleh A. Alqahtani, K. Alswat, Y. Yilmaz +51 more
2023Journal of Hepatology87 citations
Semantic Scholar
Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices
Z. Younossi, K. Corey, N. Alkhouri, M. Noureddin +11 more
2020Alimentary Pharmacology and Therapeutics83 citations
Semantic Scholar
Clinical and Patient Reported Outcomes from Patients with Non-alcoholic Fatty Liver Disease Across the World: Data from the Global NASH/NAFLD Registry.
Z. Younossi, Y. Yılmaz, Ming-Lung Yu, Vincent Wai-Sun Wong +27 more
2021Clinical Gastroenterology and Hepatology68 citations Open access
Semantic Scholar
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience
J. P. Verderese, M. Stepanova, B. Lam, A. Racila +14 more
2021Clinical Infectious Diseases60 citations Open access
Semantic Scholar
Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
Z. Younossi, Sean C. Felix, T. Jeffers, Elena Younossi +10 more
2021JAMA Network Open60 citations Open access
Semantic Scholar
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection
Z. Younossi, M. Stepanova, B. Lam, Rebecca Cable +15 more
2021Hepatology Communications51 citations Open access
Semantic Scholar
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19
M. Stepanova, B. Lam, Elena Younossi, Sean C. Felix +15 more
2022BMC Infectious Diseases50 citations Open access
Semantic Scholar
Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
S. Alqahtani, P. Golabi, James M. Paik, B. Lam +4 more
2021Obesity Surgery40 citations Open access
Semantic Scholar
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease
Z. Younossi, Saleh A. Alqahtani, Jesús Funuyet-Salas, M. Romero-Gómez +52 more
2024JHEP Reports39 citations Open access
Semantic Scholar
Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.
S. Kattakuzhy, E. Wilson, S. Sidharthan, Zayani Sims +19 more
2015Clinical Infectious Diseases32 citations Open access
Semantic Scholar
Sofosbuvir (Sovaldi) for the treatment of hepatitis C
B. Lam, L. Henry, Z. Younossi
2014Expert Review of Clinical Pharmacology27 citations
Semantic Scholar
A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis
Z. Younossi, N. Alkhouri, Kenneth Cusi, S. Isaacs +9 more
2022Alimentary Pharmacology and Therapeutics26 citations
Semantic Scholar
Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C
Yousef Fazel, B. Lam, P. Golabi, Z. Younossi
2015Expert Opinion on Drug Safety26 citations
Semantic Scholar
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.
Z. Younossi, L. de Avila, S. Petta, Hannes Hagström +82 more
2025Hepatology25 citations
Semantic Scholar
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
M. Sayiner, B. Lam, P. Golabi, Z. Younossi
2018Therapeutic Advances in Gastroenterology19 citations Open access
Semantic Scholar
Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease Using Noninvasive Tests From Primary Care and Endocrinology Real-World Practices
Z. Younossi, H. Pham, Sean C. Felix, M. Stepanova +21 more
2021Clinical and Translational Gastroenterology17 citations Open access
Semantic Scholar
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™
Z. Younossi, Ming-Lung Yu, Y. Yılmaz, K. Alswat +22 more
2023Journal of Viral Hepatitis16 citations
Semantic Scholar
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study.
Z. Younossi, L. de Avila, S. Petta, Hannes Hagström +84 more
2026Clinical Gastroenterology and Hepatology13 citations
Semantic Scholar
Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Z. Younossi, Markos Kalligeros, V. W. Wong, K. Al-Naamani +46 more
2026Clinical Gastroenterology and Hepatology12 citations
Semantic Scholar
The impact of viral hepatitis‐related hepatocellular carcinoma to post‐transplant outcomes
Z. Younossi, M. Stepanova, S. Saab, A. Ahmed +5 more
2016Journal of Viral Hepatitis12 citations
Semantic Scholar
The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
Z. Younossi, M. Stepanova, Sean C. Felix, T. Jeffers +5 more
2023Alimentary Pharmacology and Therapeutics9 citations
Semantic Scholar
Service line care delivery model for COVID-19 patient-centric care.
Ashiq Mannan, Nicholas Sutingco, S. Djurkovic, M. Reyes +25 more
2021American Journal of Managed Care8 citations
Semantic Scholar
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system
B. Lam, M. Stepanova, C. Venkatesan, I. Garcia +9 more
2022PLoS ONE7 citations Open access
Semantic Scholar
The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
Z. Younossi, Y. Yılmaz, M. El-Kassas, A. Duseja +14 more
2022Hepatology Communications6 citations Open access
Semantic Scholar
Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease.
Z. Younossi, J. Estep, Sean C. Felix, B. Lam +3 more
2024Diabetes Research and Clinical Practice5 citations
Semantic Scholar
Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute Infection
J. Price, L. Gerber, M. Stepanova, L. de Avila +14 more
2023International Journal of General Medicine5 citations Open access
Semantic Scholar
Regular Exercise Is Associated With Low Fatigue Levels and Good Functional Outcomes After COVID-19
L. de Avila, J. Price, M. Stepanova, B. Lam +16 more
2023American Journal of Physical Medicine & Rehabilitation5 citations
Semantic Scholar
Serum Biomarkers are Associated with Atherosclerotic Cardiovascular Disease among Patients with Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography.
Z. Younossi, Sean C. Felix, T. Jeffers, Elena Younossi +5 more
2021Clinical Gastroenterology and Hepatology5 citations Open access
Semantic Scholar
Major Histocompatibility Complex Class I‐Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease
Azza Karrar, Bijal Rajput, Siddharth Hariharan, Dinan Abdelatif +12 more
2020Hepatology Communications5 citations Open access
Semantic Scholar
Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States
B. Lam, J. Bartholomew, S. Bau, H. Gilles +6 more
2025Journal of Clinical Gastroenterology4 citations
Semantic Scholar
Serum Bile Acid Elevation is an Independently Associated With Pruritus in Patients With At-risk Metabolic Dysfunction-associated Steatotic Liver Disease.
Z. Younossi, M. Estep, Sean C. Felix, B. Lam +9 more
2025Journal of Clinical and Experimental Hepatology4 citations Open access
Semantic Scholar
Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women
J. Price, L. de Avila, M. Stepanova, A. Weinstein +7 more
2023International Journal of General Medicine4 citations Open access
Semantic Scholar
The Clinical and Economic Burden of Nonalcoholic Steatohepatitis
B. Lam, Kyle Kurzke, Z. Younossi
2018Current Hepatology Reports4 citations
Semantic Scholar
How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19
A. Kasarabada, Kimberly Barker, Theresa Ganoe, Lindsay Clevenger +9 more
2023PLoS ONE3 citations Open access
Semantic Scholar
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient‐Reported Outcomes
G. Papatheodoridis, M. Buti, Yusuf Yilmaz, Ming-Lung Yu +19 more
2026Journal of Gastroenterology and Hepatology2 citations Open access
Semantic Scholar
Stigma in NAFLD and NASH: a global survey of patients and providers
Z. Younossi, Y. Yılmaz, Jian-Gao Fan, V. Wong +43 more
2023Journal of Hepatology2 citations
Semantic Scholar
Inducible Nitric Oxide Synthase is Independently Associated with the Increased Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
E. Elsheikh, J. Estep, Sean C. Felix, H. Allawi +12 more
20172 citations
Semantic Scholar
Non-Hematopoietic Circulating Progenitor Cells and Presence of CoronaryArtery Disease in Patients with Non-Alcoholic Fatty Liver Disease
E. Elsheikh, T. Jeffers, Z. Younoszai, S. Hunt +7 more
20162 citations Open access
Semantic Scholar
Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease.
L. de Avila, K. Al-Naamani, M. Papatheodoridi, S. Petta +84 more
2026Journal of the American Medical Association (JAMA)1 citations Open access
Semantic Scholar
The clinical and patient reported outcomes (PROs) profile of patients with non-alcoholic fatty liver disease (NAFLD) from real-world practices varies across the world
Z. Younossi, Y. Yılmaz, Ming-Lung Yu, M. El Kassas +25 more
2020Journal of Hepatology1 citations Open access
Semantic Scholar
329 THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR)
Z. Younossi, Ming-Lun Yu, Y. Yılmaz, M. El Kassas +26 more
20201 citations
Semantic Scholar
1448-P: Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD)
Z. Younossi, Sean C. Felix, T. Jeffers, Elena Younossi +11 more
20201 citations
Semantic Scholar
Non-Alcoholic Fatty Liver is Increasingly Contributing the Number of Cases of Liver Disease (LD) Seen in the Emergency Departments (ED) in the United States (U.S.)
H. Bush, P. Golabi, M. Otgonsuren, B. Lam +3 more
20171 citations
Semantic Scholar
368 Improvement of Patient-Reported Outcomes in Older Patients With Chronic Hepatitis C (CH-C) Treated With Interferon- and Ribavirin-Free Sofosbuvir (SOF)-Containing Regimens
Z. Younossi, M. Stepanova, F. Nader, B. Lam +3 more
20151 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Z. Younossi×43
Invite
Z. Younossi — researcher profile on SciRah
A. Racila×27
Invite
A. Racila — researcher profile on SciRah
M. Stepanova×26
Invite
M. Stepanova — researcher profile on SciRah
F. Nader×20
Invite
F. Nader — researcher profile on SciRah

×15

Invite

L. Henry — researcher profile on SciRah

Invite

P. Golabi — researcher profile on SciRah

Ajay Duseja×13

Invite

Ajay Duseja — researcher profile on SciRah

Sean C. Felix×12

Invite

Sean C. Felix — researcher profile on SciRah

Invite

T. Jeffers — researcher profile on SciRah

Invite

K. Alswat — researcher profile on SciRah

Invite

J. Ong — researcher profile on SciRah

Invite

L. de Avila — researcher profile on SciRah